MC
OCEA

Meteora Capital’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Meteora Capital’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-568,398
Closed -$375K – 317
2023
Q4 		$375K Sell
568,398
-1,280,295
-69% -$1.76M 0.06% 158
2023
Q3 		$7.21M Hold
1,848,693
– – 1.23% 15
2023
Q2 		$11.1M Sell
1,848,693
-37,689
-2% -$221K 2.05% 8
2023
Q1 		$12.5M Buy
1,886,382
+1,747,625
+1,259% +$14.8M 1.48% 10
2022
Q4 		$1.44M Hold
138,757
– – 0.31% 77
2022
Q3 		$1.41M Buy
+138,757
New +$1.41M 0.36% 77

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $16.7B AUM 35.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Meteora Capital's OCEA Position: Q1 2024 in Review

Meteora Capital sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q1 2024, closing a stake of 568,398 shares — an estimated $375K sold.

Meteora Capital first reported a position in OCEA in Q3 2022 and held it in 6 quarters. The position peaked at $12.5M in Q1 2023. 46 funds tracked by Wall St. Rank hold OCEA as of Q1 2024.

  • Meteora Capital reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Meteora Capital sold 568,398 Ocean Biomedical, Inc. Common Stock shares in Q1 2024, an estimated $375K.
  • Meteora Capital first reported a position in Ocean Biomedical, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
  • Meteora Capital's Ocean Biomedical, Inc. Common Stock position peaked at $12.5M in Q1 2023.
  • 46 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q1 2024.

Based on Meteora Capital's 13F filing for Q1 2024, filed 14 May 2024.